You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股收評:滬指震盪收跌0.05%,汽車產業鏈表現活躍

7月27日,A股指數全天窄幅震盪,滬指收跌0.05%報3275點,深成指跌0.07%,創業板指漲0.03%,科創50指數漲1%。兩市2853股上漲,1770股下跌,成交額8680億元,北上資金淨賣出37.38億元。

行業板塊漲跌參半,受歐洲天然氣期貨大漲刺激,燃氣股表現突出,佛燃能源錄得5連板;工業母機概念全天強勢,秦川機牀等股漲停;汽車方向個股整體表現活躍,細分一體壓鑄概念大漲;新能源電力股午後走強,HJT電池概念大漲,隆基漲2.7%;培育鑽石概念延續昨日強勢,稀土、痘病毒防治、鈉電池等概念活躍。

燃氣股全天漲幅居前。洪通燃氣、佛然能源、德龍匯能、南京公用漲停,陝天然氣漲超7%,九豐能源漲超5%。

消息面上,歐洲天然氣價格再漲超21%,連漲兩日至4個多月來新高。此前歐盟成員國同意今冬削減天然氣用量15%,為俄羅斯斷供做好準備。

汽車熱管理板塊表現漲勢。標榜股份、湘油泵、匯得科技、銀輪股份、飛龍股份、三花智控漲停。

消息面上,飛龍股份7月26日公吿,收到重慶理想汽車有限公司常州分公司供應商定點意向書,公司成為理想汽車某項目熱管理模塊/EGR冷卻閥的供應商。

工業母機板塊表現活躍。禾川科技、華東重機、秦川機牀漲停,拓斯達漲超11%,伊之密漲超10%。

隨着中國製造業加速轉型以及精密模具、航空航天、軌道交通、生物醫藥等新興產業迅速崛起,由於其生產製造過程高度依賴數控機牀等智能製造裝備,將成為數控機牀行業新的增長點。機構預計,到2026年中國數控機牀市場規模將突破5000億元。

培育鑽石板塊延續昨日漲勢。力量鑽石漲超9%,晶盛機電、國機精工漲超6%,沃爾德漲超4%,黃河旋風漲超2%。

浙商證券表示,新能源汽車滲透率突破10%後實現“陡峭式增長”,培育鑽石有望複製其成長性,預計2022~2025年全球培育鑽石原石需求價值量從143億元增至313億元,年均複合增速達30%,預計行業供不應求態勢將維持至2025年。

酒店及餐飲板塊回調。君亭酒店跌逾4%,同慶樓、華天酒店跌逾3%。錦江酒店、西安旅遊跌逾2%。

景點及旅遊板塊跟隨走弱。天目湖跌逾4%,雲南旅遊、眾信旅遊、張家界、宋城演藝跌逾2%。

房地產板塊集體走低。信達地產跌逾6%,南國置業、藍光發展跌逾4%,光大嘉寶、天保基建、渝開發跌逾3%。

消息面上,7月26日,一張標註着鄭州市住房保障和房地產局7月20日發佈的文件截圖在網絡流傳,文件名為《關於我市頭部房企自願退出項目情況的彙報》。文件本意是政府計劃幫助在鄭頭部優質房企解決當下遇到的困難,履行國家“保交付、保生產、保民生”的三保要求,對7家頭部房企優先幫助紓困。

個股異動方面,藥明康德大跌5.12%,報96.36%,總市值為2849億元。消息面上,藥明康德上半年實現營收177.56億元,同比增長68.52%;淨利潤46.36億元,同比增長73.29%。藥明康德Q1淨利16.43億元,據此計算,Q2淨利29.93億元,環比增長82%。

藥明康德在中期業績交流會上表示,隨着業務規模增大,公司下半年收入會增速,效率也會不斷體現,預計今年全年毛利率水平同比去年有所提升,全年經調整Non-IFRS增速會高於收入增速。其中,預計未來3-5年,化學業務 (WuXi Chemistry)板塊收入增速將保持在行業平均增長率兩倍的水平。

猴痘概念股今日下午異動拉昇隨後回落,之江生物收漲10%。消息面上,據美國疾病控制中心CDC官網最新數據顯示,全球新增1093例猴痘疫情確診病例,累計猴痘疫情病例確診數量達到19188例,覆蓋全球76個國家和地區。

北向資金方面,北上資金淨流出11.7億元,其中滬股通淨流出4.69億元,深股通淨流出7.01億元

展望後市,中信建投策略認為,市場從單邊修復期進入震盪期。結構上,新能源高景氣預期維持但擁擠度在上升,部分消費品景氣有望邊際改善但整體估值吸引力不強,醫藥景氣邊際改善邏輯不強但前期機構持續降低配置。我們認為這個階段投資者需要保持耐心,相對收益者可考慮均衡配置成長,絕對收益者可考慮中性倉位,等待外部催化下顯著調整後結構上再加碼高β高景氣成長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account